Orthopedic 13Fs: Zimmer Biomet, Stryker, Smith+Nephew, Globus

US-traded orthopedic medical device equities form a distinctive medtech corner of institutional 13F positioning. Zimmer Biomet (ZBH), Stryker (SYK, Orthopaedics segment plus Mako robotic surgery), Smith+Nephew (SNN, UK-domiciled US ADR), Globus Medical (GMED, post-NuVasive merger September 2023), Medtronic Spinal (within MDT), Enovis (ENOV, formerly Colfax post-Lifeward emerging), plus SI-BONE (SIBN) anchor the cohort. Multi-year emerging robotic orthopedic surgery adoption, aging demographics, plus emerging emerging GLP-1 dynamics drive distinctive institutional positioning. Reading orthopedic 13F positioning requires understanding the procedure framework plus the multi-year category dynamics.

The orthopedic business model

Orthopedic companies operate four primary economic engines:

1. Joint replacement economics. Multi-year emerging joint replacement economics drives operator revenue. Multi-year emerging knee replacement plus emerging emerging hip replacement plus emerging emerging shoulder replacement plus emerging emerging emerging emerging ankle plus emerging emerging emerging emerging extremities drive multi-year emerging emerging procedure volume. Multi-year emerging emerging Centers for Medicare and Medicaid Services (CMS) outpatient migration plus emerging emerging emerging emerging Ambulatory Surgery Center (ASC) shift plus emerging emerging emerging emerging emerging emerging same-day discharge drive multi-year emerging operator economics.
2. Spine surgery dynamics. Multi-year emerging spine surgery dynamics drives Globus Medical plus Medtronic Spinal plus emerging emerging Stryker plus emerging emerging Johnson & Johnson DePuy Synthes operator economics. Multi-year emerging cervical plus emerging emerging emerging emerging lumbar plus emerging emerging emerging emerging deformity plus emerging emerging emerging minimally invasive spine drive multi-year emerging procedure volume. Multi-year emerging emerging Globus-NuVasive merger (September 2023) reshapes spine industry.
3. Robotic orthopedic surgery. Multi-year emerging robotic orthopedic surgery drives multi-year emerging operator competitive positioning. Multi-year emerging Stryker Mako (knee plus hip plus emerging emerging shoulder) plus emerging emerging Smith+Nephew Cori plus emerging emerging Zimmer Biomet ROSA plus emerging emerging Johnson & Johnson Velys (Tibial Knee robotic) plus emerging emerging Globus Medical Excelsius plus emerging emerging Medtronic Mazor plus emerging emerging emerging emerging Brainlab drive multi-year emerging robotic orthopedic adoption. Multi-year emerging emerging Mako installed base 1,500+ systems globally.
4. GLP-1 dynamics emerging. Multi-year emerging GLP-1 dynamics drives multi-year emerging orthopedic operator positioning. Multi-year emerging GLP-1 weight loss reduces obesity-related joint stress plus emerging emerging emerging emerging may delay joint replacement procedures plus emerging emerging emerging emerging weight loss may enable joint replacement at younger patients. Multi-year emerging emerging GLP-1 net impact on joint procedure volume uncertain plus emerging emerging emerging emerging multi-year emerging emerging long-term aging demographics tailwind continues.

Major US orthopedic names

Zimmer Biomet (ZBH)

Largest US joint replacement plus emerging emerging Knee plus emerging emerging Hip plus emerging emerging S.E.T. (Sports, Extremities, Trauma) plus emerging emerging ROSA robotic plus emerging emerging operational scaling plus emerging emerging Ivan Tornos CEO leadership.

Stryker (SYK)

Diversified Orthopaedics plus emerging emerging Medical Surgical plus emerging emerging Neurotechnology plus emerging emerging Mako robotic surgery (knee plus hip plus emerging emerging shoulder) plus emerging emerging Kevin Lobo CEO leadership.

Smith+Nephew (SNN)

UK-domiciled diversified Orthopaedics plus emerging emerging Sports Medicine plus emerging emerging Advanced Wound Management plus emerging emerging Cori robotic surgery plus emerging emerging Deepak Nath CEO leadership.

Globus Medical (GMED)

Diversified spine plus emerging emerging post-NuVasive merger (September 2023) plus emerging emerging Excelsius robotic surgery plus emerging emerging Dan Scavilla CEO leadership.

Medtronic Spinal (within MDT)

Medtronic Cranial & Spinal Technologies segment plus emerging emerging Mazor robotic plus emerging emerging operational scaling within Medtronic.

Enovis (ENOV)

Diversified Prevention & Recovery plus emerging emerging Reconstruction plus emerging emerging Lifeward emerging plus emerging emerging Matt Trerotola CEO leadership.

SI-BONE (SIBN)

Pure-play sacroiliac joint fusion plus emerging emerging iFuse plus emerging emerging operational scaling plus emerging emerging Laura Francis CEO leadership.

How institutional managers position around orthopedic

Three patterns appear across smart-money 13Fs:

Pattern 1: Quality-compounder concentration

SYK-concentrated growth manager positions reflect quality orthopedic compounding plus emerging emerging Mako robotic thesis.

Pattern 2: Spine-consolidation positioning

GMED-concentrated growth manager positions reflect Globus-NuVasive consolidation plus emerging emerging Excelsius robotic thesis.

Pattern 3: Turnaround positioning

ZBH-concentrated value-discipline manager positions reflect Zimmer Biomet turnaround plus emerging emerging ROSA scaling thesis.

How to read orthopedic 13F positioning

Three rules apply:

Rule 1: Identify procedure exposure

Joint replacement vs spine vs extremities have distinct dynamics.

Rule 2: Watch procedure volume

Multi-year procedure volume drives operator revenue.

Rule 3: Cross-check robotic adoption

Multi-year robotic surgery drives operator competitive positioning.

What orthopedic positioning signals

1. Quality-compounder conviction. Concentrated SYK positions signal quality orthopedic thesis.
2. Spine-consolidation conviction. Concentrated GMED positions signal Globus-NuVasive thesis.
3. Turnaround conviction. Concentrated ZBH positions signal Zimmer Biomet turnaround thesis.

For real-time tracking of orthopedic 13F activity, see the institutional signals feed.